Preimplantation genetic screening (PGS) still in search of a clinical application: a systematic review.

Newly updated “PGS#2” faces a multitude of issues, chief among them appropriate patient selection. With its efficacy still unproven, the technique should be offered only on an experimental basis.

Norbert Gleicher, MD, leads CHR’s clinical and research efforts as Medical Director and Chief Scientist. A world-renowned reproductive endocrinologist, Dr. Gleicher has published hundreds of peer-reviewed papers and lectured globally while keeping an active clinical career focused on ovarian aging, immunological issues and other difficult cases of infertility.

Citation Page #: 12:22.
Journal: Reprod Biol Endocrinol
Author Publication: Gleicher N, Kushnir VA, Barad DH.
Publication Link: http://www.rbej.com/content/12/1/22
Date: 2014